Notas do episódio
After a breast cancer diagnosis in 2020, followed by a single mastectomy and DIEP flap reconstruction, Elle thought her next surgery would be a revision.
Then updated genetic testing revealed a CHEK2 pathogenic variant and changed the decision in front of her.
In Part 1, Elle shares how she decided to have a risk-reducing mastectomy on her remaining breast, and why choosing what type of reconstruction was right for her felt so difficult.
We talk about:
• updated genetic testing after breast cancer
• deciding on risk-reducing mastectomy
• reconstruction options after DIEP
• staying flat…
Site: shows.acast.com

